Nurix Therapeutics, Inc. — All Filings
486 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001950047-25-005336 | Aug 1, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000103 | Aug 1, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000100 | Jul 30, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000101 | Jul 30, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000099 | Jul 30, 2025 | — |
| 10-Q | 10-Q | 0001549595-25-000095 | Jul 9, 2025 | May 31, 2025 |
| 8-K | 8-K | 0001549595-25-000094 | Jul 9, 2025 | — |
| 8-K | 8-K | 0001549595-25-000086 | Jun 12, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000079 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000080 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000081 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000082 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000078 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000076 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000083 | May 19, 2025 | — |
| 8-K | 8-K | 0001549595-25-000067 | May 19, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000077 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-001967 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-001535 | May 12, 2025 | — |
| SCHEDULE 13G/A | — | 0000902219-25-000191 | May 12, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000063 | May 2, 2025 | — |
| 144 | — | 0001950047-25-002704 | May 2, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000059 | Apr 30, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000060 | Apr 30, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000061 | Apr 30, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001517 | Apr 23, 2025 | — |
| 8-K | 8-K | 0001549595-25-000053 | Apr 8, 2025 | — |
| 10-Q | 10-Q | 0001549595-25-000055 | Apr 8, 2025 | Feb 28, 2025 |
| DEFA14A | DEFA14A | 0001140361-25-010810 | Mar 28, 2025 | — |
| DEF 14A | DEF 14A | 0001140361-25-010808 | Mar 28, 2025 | May 19, 2025 |
| ARS | ARS | 0001140361-25-010874 | Mar 28, 2025 | Nov 30, 2024 |
| UPLOAD | — | 0000000000-25-002962 | Mar 19, 2025 | — |
| CORRESP | — | 0001193125-25-054054 | Mar 13, 2025 | — |
| 8-K | 8-K | 0001549595-25-000043 | Mar 13, 2025 | Mar 11, 2025 |
| 3 | FORM 3 | 0001549595-25-000044 | Mar 13, 2025 | Mar 11, 2025 |
| 4 | FORM 4 | 0001549595-25-000045 | Mar 13, 2025 | Mar 11, 2025 |
| 144 | — | 0001950047-25-001394 | Mar 3, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000037 | Mar 3, 2025 | — |
| UPLOAD | — | 0000000000-25-002308 | Feb 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-000876 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001493152-25-006846 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-001186 | Feb 14, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000035 | Feb 13, 2025 | Feb 11, 2025 |
| 4 | FORM 4 | 0001549595-25-000032 | Feb 13, 2025 | Feb 11, 2025 |
| 4 | FORM 4 | 0001549595-25-000033 | Feb 13, 2025 | Feb 11, 2025 |
| 4 | FORM 4 | 0001549595-25-000034 | Feb 13, 2025 | Feb 11, 2025 |
| 4 | FORM 4 | 0001549595-25-000026 | Feb 3, 2025 | Jan 31, 2025 |
| 144 | — | 0001950047-25-000527 | Jan 31, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000020 | Jan 30, 2025 | — |
| 4 | FORM 4 | 0001549595-25-000022 | Jan 30, 2025 | — |